Brigid Riordan
Primary Care · Norco, CANPI 1568835833
Payments from drug & device makers
Across 133 payments — averaging $22.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$437
- Novo Nordisk$394
- Lilly USA, LLC$375
- Biohaven Pharmaceutical Holding Company Ltd.$325
- Pfizer$281
- AstraZeneca$250
- plus $901 from 15 others
What the payments were for
- Food & beverage$2,962100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $437 |
| Novo Nordisk | 16 | $394 |
| Lilly USA, LLC | 24 | $375 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $325 |
| Pfizer | 18 | $281 |
| AstraZeneca | 9 | $250 |
| Biohaven Pharmaceuticals, Inc. | 6 | $176 |
| Boehringer Ingelheim | 7 | $155 |
| Astellas Pharma US Inc | 5 | $137 |
| Dexcom, Inc. | 6 | $114 |
| Merck | 4 | $82 |
| GSK | 2 | $50 |
| Johnson & Johnson | 2 | $37 |
| Covis Pharma GmbH | 2 | $28 |
| Abbott | 1 | $26 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Bayer | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$203
- UBRELVY$125
How this compares
$2,962 in reported general payments places this provider in the 90th percentile of 706 primary care providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 32 | $35,976 |
| OzempicSemaglutide | 25 | $23,491 |
| MyrbetriqMirabegron | 18 | $19,862 |
| FarxigaDapagliflozin Propanediol | 27 | $19,345 |
| RybelsusSemaglutide | 12 | $18,377 |
| Spiriva HandihalerTiotropium Bromide | 13 | $6,558 |
| Naloxone Hcl | 45 | $2,278 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 88 | $2,050 |
| Tramadol Hcl | 41 | $1,683 |
| LantusInsulin Glargine,hum.Rec.Anlog | 21 | $1,674 |
| Nifedipine ErNifedipine | 50 | $1,530 |
| Omeprazole | 73 | $1,426 |
| Duloxetine Hcl | 19 | $1,397 |
| Levothyroxine Sodium | 102 | $1,337 |
| Rosuvastatin Calcium | 113 | $1,321 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $394 | $41,86837 claims |
| PfizerEliquis | $281 | $35,97632 claims |
| Astellas Pharma US IncMyrbetriq | $137 | $19,86218 claims |
| AstraZenecaFarxiga | $250 | $19,34527 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 706 primary care providers in California.
Other primary care in Norco
- Leslie FletcherTorrance$1.8M
- Hamideh PourzandLos Angeles$103K
- Veronica RamirezSacramento$83K
- Tyson FieldstedBakersfield$65K
- Joann BallPalm Desert$56K
- Kathryn CooperSan Diego$31K
- Shalaine Corbillala Mesa$22K
- Paula StoddardHanford$22K
- Ashley LoweSan Diego$19K
- Vanessa LeeLong Beach$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.